Discover trends, market shifts, and competitive outlooks for the cell viability assays industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Cell Viability Assays Market Size from 2025 to 2034?

The market for cell viability tests has seen a steep increase in its size of late. Its growth is projected to continue from $1.56 billion in 2024 to reach $1.73 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.8%. The escalation in the erstwhile period can be connected to increased funding for cancer studies, a climb in pharmaceutical research & development spending, an expansion in the biotech sector, enhanced progress in cell culture methodologies, an uprising demand for stem cell research, a higher necessity for toxicity screening, a rise in the application of real-time cell analysis systems, and an escalating count of CROs (contract research organizations).

Anticipations are high for the cell viability assays market as it is predicted to experience swift expansion in the coming years, with its value anticipated to reach $2.58 billion by 2029, showing a compound annual growth rate (CAGR) of 10.5%. Numerous factors will contribute to this growth during the forecast period, including increased demand for personal medicine, higher government investment in cell-based studies, intensified focus on precision medicine, and growth in stem cell research and its applications. Other attributors include the rising availability of automated cell viability analyzers, increased cases of infectious diseases, emphasis on enhancing assay precision and sensitivity, expanded awareness about the advantages of cell viability assays, development in organ-on-chip technology, and a surge in demand for regenerative medicines. The forecast period trends are expected to be determined by advancements in high throughput screening techniques, the integration of AI and machine learning protocols, the invention of real-time tracking systems, utilization of automated liquid management systems, creation of multiplex assays for concurrent cell viability measurements, encouraging the use of sustainable and environmentally-friendly reagents, the design of user-friendly assay kits, progressions in electrochemical assays, the execution of scalable cell viability assays, and the designing of assays harmonious with primary cells and stem cells.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Cell Viability Assays Market?

The surge in cell-based therapeutics is set to promote the expansion of the cell viability assay market. Cell-based therapies, which utilize living cells to mend or replace injured tissue, treat ailments, or regain normal function, are enhancing the growth. This progress is powered by developments in the field of biotechnology, amplified funding in regenerative medicine, rising acceptance and deployment of cell therapies, and enhancements in cell engineering and production technologies. Cell viability assays bolster cell-based therapeutics by assuring the well-being, functionality, and safety of therapeutic cells, thus maximizing treatment effectiveness and quality supervision. For example, the American Society of Gene & Cell Therapy, a not-for-profit medical and scientific organization located in the US, launched 38 trials for non-genetically altered cell therapies in Q1 2023, an increase of seven from the preceding quarter, Q4 2022. Consequently, the boost in cell-based therapeutics is stimulating the growth of the cell viability assay market.

Which Segments in the Cell Viability Assays Offer the Most Growth?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

What Are the Fastest-Growing Geographies in the Cell Viability Assays Market?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering the Cell Viability Assays Market Direction?

In the cell viability assays market, significant businesses are innovating cell screening technologies to enhance precision and hasten drug discovery. Cell screening methodologies augment cell viability assays by facilitating high-throughput, accurate, and quick examination of cell health and reactions, thereby refining experimental conditions and upgrading the creation of therapeutic strategies. For example, in May 2024, Arralyze, a tech firm based in Germany, rolled out CellShepherd, a state-of-the-art platform for single-cell analysis. The platform uses its own nanowell glass arrays to miniaturize cell-based assays for continuous monitoring. The standalone system allows for precise cell dispensing, co-culturing in sterile environments, and imaging with brightfield and fluorescent channels. Thanks to AI-driven evaluation, it ensures precise cell counting and tracking. This user-friendly platform meets the growing demand for accurate single-cell study in biomedical and life-science applications.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Are the Key Elements That Define the Cell Viability Assays Market?

Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model